Sarepta Therapeutics reported $56.21M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 10.77M 3.89M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Avrobio Inc AVRO:US 4.04M 551K
Biogen BIIB:US $ 434.8M 36.1M
Daiichi Sankyo 4568:JP Y 330282M 5498M
Eli Lilly And LLY:US $ 1659.3M 226M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Insmed INSM:US $ 31.14M 17.43M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
IONIS PHARMACEUT IONS:US $ 16.12M 4.22M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Moderna Inc MRNA:US 181M 18M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Newlink Genetics NLNK:US 1.8M 1.19M
Novavax NVAX:US $ 135.13M 8.08M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Regeneron Pharmaceuticals REGN:US $ 534.2M 63.9M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
YTE INCY:US $ 194.77M 42.22M